Christopher Gibson
Director · 14 filings · Latest: Jun 5, 2026
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
RECURSION PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RXRX | Gibson Christopher | — | Feb 6, 2025 | Proposed Sale | $8.12 | 20,000 | $162.4K | — | |
RXRX | Gibson Christopher | — | Feb 5, 2025 | Proposed Sale | $7.68 | 20,000 | $153.6K | — | |
RXRX | Gibson Christopher | — | Jan 10, 2025 | Proposed Sale | $7.05 | 20,000 | $141.0K | — | |
RXRX | Gibson Christopher | — | Jan 8, 2025 | Proposed Sale | $7.31 | 20,000 | $146.2K | — | |
RXRX | Gibson Christopher | — | Dec 5, 2024 | Proposed Sale | $7.12 | 20,000 | $142.4K | — | |
RXRX | Gibson Christopher | — | Dec 4, 2024 | Proposed Sale | $7.16 | 20,000 | $143.2K | — | |
RXRX | Gibson Christopher | — | Nov 14, 2024 | Proposed Sale | $7.35 | 20,000 | $147.0K | — | |
RXRX | Gibson Christopher | — | Nov 13, 2024 | Proposed Sale | $7.74 | 20,000 | $154.8K | — | |
RXRX | Gibson Christopher | — | Oct 3, 2024 | Proposed Sale | $6.08 | 20,000 | $121.6K | — | |
RXRX | Gibson Christopher | — | Oct 2, 2024 | Proposed Sale | $6.16 | 20,000 | $123.2K | — | |
RXRX | Gibson Christopher | — | Sep 5, 2024 | Proposed Sale | $6.14 | 20,000 | $122.8K | — | |
RXRX | Gibson Christopher | — | Sep 4, 2024 | Proposed Sale | $6.04 | 20,000 | $120.8K | — |
← Previous
Page 4 of 4